According to Future Market Insights (FMI) analysis in a recent market survey, the global spasticity treatment market was valued at USD 12.2 Billion in 2022 and is set to reach USD 28.4 Billion by 2033.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | USD 12.2 Billion |
| Market Value 2023 | USD 13.1 Billion |
| Market Value 2033 | USD 28.4 Billion |
| CAGR 2023 to 2033 | 8.1% |
| Share of Top 5 Countries | 54.0% |
| Key Players | Medtronic Plc; Piramal Enterprises Ltd.; AbbVie, Inc. (Allergan); Ipsen Pharma; F. Hoffmann-La Roche Ltd; GlaxoSmithKline plc; Pfizer Inc.; Elite Pharmaceuticals Inc.; Orient Pharma; Acorda Therapeutics, Inc.; Sun Pharmaceutical Industries Ltd; Novartis AG (Alcon); Teva Pharmaceutical Industries Ltd; Zydus Cadila Healthcare Ltd.; Beximco Pharmaceuticals Ltd; Merz Pharma; Thought Technology Ltd.; UltraCare PRO; Invacare Corporation; ATI Physical Therapy; P.T. Services Rehabilitation, Inc.; Banner Health. |
Spasticity is one of many clinical traits or motor behavior that can appear following injury to the area of the brain or spinal cord that regulates voluntary movements. Upper motor neuron syndrome is the term used to describe these symptoms taken together.
One of the key factors promoting the growth of the spasticity treatment market is the rising prevalence of neuro-musculoskeletal disorders. Spasticity is becoming more common as chronic neuro-musculoskeletal illnesses become more common on a global scale.
The high prevalence of these illnesses worldwide is a result of an increase in slips, accidents, assaults, and other incidents. A diagnosis of spasticity was made in more than 50% to 60% of these cases. The global market thus benefits from the rising prevalence of various chronic disorders due to the close association between the aforementioned chronic conditions and spasticity. This rising incidence will drive market expansion over the forecast period.
Overall, the adoption of spasticity treatment in healthcare facilities, which will boost the market in the coming years.
Sales of the global market grew at a CAGR of 5.4% between 2012 and 2022. Spasticity treatment market contributes 29.6% revenue share to the global neurodegenerative disease treatment market value at USD 41.2 Billion in 2022.
The ageing population is one of the primary factors fueling the market for spasticity treatments.
Age-related changes in the brain, traumas like stroke or traumatic brain damage, addiction, and diseases like multiple sclerosis (MS), stroke, and brain tumours, among others, can all have a substantial impact on brain health, which will increase the prevalence of spasticity and its related indications, which will boost the market for spasticity treatments.
Advanced procurement operations provide businesses and manufacturers with chances to develop and expand their clientele to buyers and suppliers that collaborate to create cutting-edge products that increase sales and profits for all parties. By implementing several techniques into their processes, they adopt an integrated approach to creating new goods and procedures.
Different key strategies such as new product launches, acquisitions, collaborations, and expansion are being used by companies and different manufacturers for the advancement and development of new products and therapies.
Considering this, FMI expects the global market to grow at a CAGR of 8.1% through the forecasted years.
Cognitive knowledge and evaluation of everyday things and issues is one of the most important indicators of a person's mental health and ability to think and act in life-or-death situations.
The brain is a sophisticated organ that has a significant impact on one's overall health and well-being. Brain health can be significantly impacted by ageing-related changes in the brain and traumas like stroke or traumatic brain injury. While certain factors that affect brain health cannot be avoided, there are other lifestyle changes that can be beneficial.
Since they improve brain glucose metabolism and reduce the risk of mental disorders, improved brain and mental fitness is becoming more and more in demand, opening up new treatment options for spasticity.
Increased testing of combination therapies in patients will pave the way for new drug discoveries and treatment options, ultimately leading to the introduction of new products into the market.
For the spasticity treatment process, there is a requirement of skilled specialists such as physiatrists, neurologists, rehabilitation nurses, physical and occupational therapists, speech and language pathologists, psychologists, social workers, recreational therapists, etc.
The non-availability and limited number of such well-trained specialists can have an adverse impact on the treatment of patients with spasticity and also lower the growth of the organizations that are involved in the treatment. Due to these factors, the quality of services can get affected, and this will ultimately have a negative impact on the growth of the spasticity treatment market.
The dearth of skilled professionals in these fields can lower the quality of services offered, ultimately affecting the growth of the spasticity treatment market.
These factors are expected to hamper revenue growth of the global market over the forecast period.
The USA market dominated the global market with value of around USD 3.63 Bilion in 2022 and is expected to register a CAGR of 8.3% during the forecast period.
The high prevalence of spasticity in the United States will accelerate the acceptance of various treatment alternatives.
Due to the high prevalence, more treatments, including over-the-counter products, will experience a high adoption rate among patients. The demand for spasticity treatment will increase due to high prevalence, which will drive the expansion of the market.
Germany dominated the European market for spasticity treatment and accounted for around 22.3% of the regional market share in 2022.
Increasing technological advancements in spasticity treatment therapies in Germany is driving the overall Europe spasticity treatment market.
Virtual reality technology can be used to provide immersive therapy experiences for patients with spasticity. These experiences can help patients to improve their motor skills and reduce spasticity through interactive and engaging activities. This therapy has been found to be effective in reducing spasticity in patients with cerebral palsy, multiple sclerosis, and other neurological conditions.
The safe and successful spasticity treatment therapies in Germany will influence other European countries to also opt for this treatment method, ultimately expanding the overall market.
China is projected to be the most attractive market in the East Asia region, and is expected to grow over a significant CAGR of 7.7% during the forecast duration.
The spasticity treatment market in China is expected to grow significantly in the coming years due to several factors.
One of the main factors driving the growth of the spasticity treatment market in China is the increasing awareness of the condition among the general public and healthcare professionals. As more people become aware of the condition, they are more likely to seek treatment, which is leading to increased demand for treatments for spasticity.
Another factor contributing to the growth of the spasticity treatment market in China is the increasing availability of advanced medical technologies and treatments. China has made significant investments in its healthcare infrastructure, and many new hospitals and clinics have been built in recent years. This has allowed for the introduction of advanced treatments such as botox injections and surgery, which were not widely available in the past.
The treatment segment utilizing drugs, physical therapy, Botulinum toxin, surgical treatment and others treatment options held the major chunk of about 68.4% in global market by the end of 2022.
With advances in medical technology, it has become easier to diagnose spasticity accurately. This has led to more people being diagnosed with the condition, which in turn has increased the demand for treatment. There is now more awareness about spasticity among healthcare providers, patients, and the general public. This has helped to reduce the stigma associated with the condition and encouraged more people to seek treatment.
There have been significant advances in the development of new treatments for spasticity, including medications, physical therapy, and surgical procedures. These treatments can help to reduce spasticity and improve overall quality of life for people with the condition.
The Cerebral Palsy segment held the major chunk of about 14.4% in global market by the end of 2022.
Increased awareness of cerebral palsy and improved diagnostic techniques have led to more accurate diagnosis and reporting of cases, contributing to the observed increase in prevalence. Certain risk factors, such as maternal infections during pregnancy, prematurity, and low birth weight, have become more common in recent years. This has contributed to the increase in the incidence of cerebral palsy and spasticity.
The hospital pharmacies segment accounted for revenue share of 38.3% in the global market at the end of 2022.
Hospital pharmacies offer convenient access to treatment options, with many providing over-the-counter and prescription medications for a range of conditions, including cerebral palsy, multiple sclerosis among others. Patients can typically purchase these treatments without an appointment, making it more convenient for them to manage their condition.
Overall, hospital pharmacies offers a convenient and accessible distribution channel for spasticity treating products, making it the largest channel for these treatments.
The hospitals segment accounted for revenue share of 37.1% in the global market at the end of 2022.
Hospitals typically have access to a wide range of specialized medical professionals, including neurologists, physiatrists, orthopedic surgeons, and physical therapists, who can collaborate to provide comprehensive spasticity treatment.
Overall, hospitals are a leading segment for spasticity treatment because they provide access to specialized medical professionals, advanced diagnostic tools, multimodal treatments, specialized equipment and facilities, and both inpatient and outpatient services.
Key players in the market are focused on increase their product portfolio to strengthen their position in the spasticity treatment market, and also to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain competitive edge in the market are the pricing strategies, market strategies, technological advancements, regulatory compliance and acquisition of other companies to expand their business.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the spasticity treatment market space, which are available in the full report
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2012 to 2022 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Russia, BENELUX, Nordics, India, Thailand, Indonesia, Malaysia, Philippines, Vietnam, China, Japan, South Korea, Australia, New Zealand, Türkiye, South Africa, North Africa and GCC Countries |
| Key Segments Covered | Diagnosis & Treatment Type, Indication, Distribution Channel, Service Providers, and Region |
| Key Companies Profiled | Medtronic Plc; Piramal Enterprises Ltd.; AbbVie, Inc. (Allergan); Ipsen Pharma; F. Hoffmann-La Roche Ltd; GlaxoSmithKline plc; Pfizer Inc.; Elite Pharmaceuticals Inc.; Orient Pharma; Acorda Therapeutics, Inc.; Sun Pharmaceutical Industries Ltd; Novartis AG (Alcon); Teva Pharmaceutical Industries Ltd; Zydus Cadila Healthcare Ltd.; Beximco Pharmaceuticals Ltd; Merz Pharma; Thought Technology Ltd.; UltraCare PRO; Invacare Corporation; ATI Physical Therapy; P.T. Services Rehabilitation, Inc.; Banner Health |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
Table 01: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 02: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 03: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 04: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 05: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 06: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 07: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 08: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 09: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 10: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 11: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region
Table 12: Global Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region
Table 13: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 14: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 15: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 16: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 17: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 18: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 19: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 20: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 21: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 22: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 23: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 24: North America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 25: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 26: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 27: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 28: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 29: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 30: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 31: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 32: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 33: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 34: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 35: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 36: Latin America Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 37: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 38: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 39: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 40: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 41: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 42: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 43: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 44: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 45: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 46: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 47: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 48: Europe Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 49: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 50: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 51: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 52: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 53: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 54: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 55: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 56: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 57: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 58: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 59: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 60: South Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 61: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 62: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 63: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 64: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 65: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 66: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 67: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 68: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 69: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 70: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 71: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 72: East Asia Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 73: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 74: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 75: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 76: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 77: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 78: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 79: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 80: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 81: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 82: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 83: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 84: Oceania Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 85: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 86: Middle East and Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Country
Table 87: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 88: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 89: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 90: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Diagnosis & Treatment Type
Table 91: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 92: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Indication
Table 93: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 94: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Distribution Channel
Table 95: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Table 96: Middle East & Africa Market Size (US$ Million) Analysis 2012 to 2022 and Forecast 2023 to 2033, By Service Provider
Figure 01: Global Market Size (US$ Million) Analysis, 2012 to 2022
Figure 02: Global Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033
Figure 03: Global Market Absolute $ Opportunity Analysis, 2022-2033
Figure 04: Global Market Analysis By Diagnosis & Treatment Type –2022 & 2033
Figure 05: Global Market Y-o-Y Growth Projections By Diagnosis & Treatment Type , 2023 to 2033
Figure 06: Global Market Attractiveness, By Diagnosis & Treatment Type, 2022- 2032
Figure 07: Global Market Analysis By Indication –2022 & 2033
Figure 08: Global Market Y-o-Y Growth Projections By Indication , 2023 to 2033
Figure 09: Global Market Attractiveness, By Indication, 2022- 2032
Figure 10: Global Market Analysis by Distribution Channel –2022 & 2033
Figure 11: Global Market Y-o-Y Growth Projections by Distribution Channel , 2023 to 2033
Figure 12: Global Market Attractiveness, by Distribution Channel, 2022- 2032
Figure 13: Global Market Analysis By Service Provider–2022 & 2033
Figure 14: Global Market Y-o-Y Growth Projections By Service Provider, 2023 to 2033
Figure 15: Global Market Attractiveness, By Service Provider, 2023 to 2033
Figure 16: Global Market Analysis by Region–2022 & 2033
Figure 17: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033
Figure 18: Global Market Attractiveness, By Region, 2023 to 2033
Figure 19: North America Market Value Share, By Diagnosis & Treatment Type 2023 (E)
Figure 20: North America Market Value Share, By Indication 2023 (E)
Figure 21: North America Market Value Share, by Distribution Channel 2023 (E)
Figure 22: North America Market Value Share, by Service Provider 2023 (E)
Figure 23: North America Market Value Share, by Country 2023 (E)
Figure 24: North America Market Size (US$ Million) Analysis, 2012 to 2022
Figure 25: North America Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033
Figure 26: North America Market Attractiveness Analysis , by Country
Figure 27: North America Market Attractiveness Analysis, By Diagnosis & Treatment Type
Figure 28: North America Market Attractiveness, By Indication
Figure 29: North America Market Attractiveness Analysis , by Distribution Channel
Figure 30: North America Market Attractiveness Analysis, By Service Provider
Figure 31: USA Market Value Proportion Analysis, 2022
Figure 32: Global Vs. USA Growth Comparison, 2022-2033
Figure 33: USA Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 34: USA Market Share Analysis (%), By Indication, 2022 & 2033
Figure 35: USA Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 36: USA Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 37: Canada Market Value Proportion Analysis, 2022
Figure 38: Global Vs. Canada Growth Comparison, 2022-2033
Figure 39: Canada Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 40: Canada Market Share Analysis (%), By Indication, 2022 & 2033
Figure 41: Canada Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 42: Canada Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 43: Latin America Market Value Share, By Diagnosis & Treatment Type 2023 (E)
Figure 44: Latin America Market Value Share, By Indication 2023 (E)
Figure 45: Latin America Market Value Share, by Distribution Channel 2023 (E)
Figure 46: Latin America Market Value Share, by Service Provider 2023 (E)
Figure 47: Latin America Market Value Share, by Country 2023 (E)
Figure 48: Latin America Market Size (US$ Million) Analysis, 2012 to 2022
Figure 49: Latin America Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033
Figure 50: Latin America Market Attractiveness Analysis , by Country
Figure 51: Latin America Market Attractiveness Analysis, By Diagnosis & Treatment Type
Figure 52: Latin America Market Attractiveness, By Indication
Figure 53: Latin America Market Attractiveness Analysis , by Distribution Channel
Figure 54: Latin America Market Attractiveness Analysis, By Service Provider
Figure 55: Brazil Market Value Proportion Analysis, 2022
Figure 56: Global Vs. Brazil Growth Comparison, 2022-2033
Figure 57: Brazil Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 58: Brazil Market Share Analysis (%), By Indication, 2022 & 2033
Figure 59: Brazil Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 60: Brazil Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 61: Mexico Market Value Proportion Analysis, 2022
Figure 62: Global Vs. Mexico Growth Comparison, 2022-2033
Figure 63: Mexico Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 64: Mexico Market Share Analysis (%), By Indication, 2022 & 2033
Figure 65: Mexico Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 66: Mexico Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 67: Argentina Market Value Proportion Analysis, 2022
Figure 68: Global Vs. Argentina Growth Comparison, 2022-2033
Figure 69: Argentina Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 70: Argentina Market Share Analysis (%), By Indication, 2022 & 2033
Figure 71: Argentina Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 72: Argentina Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 73: Europe Market Value Share, By Diagnosis & Treatment Type 2023 (E)
Figure 74: Europe Market Value Share, By Indication 2023 (E)
Figure 75: Europe Market Value Share, by Distribution Channel 2023 (E)
Figure 76: Europe Market Value Share, by Service Provider 2023 (E)
Figure 77: Europe Market Value Share, by Country 2023 (E)
Figure 78: Europe Market Size (US$ Million) Analysis, 2012 to 2022
Figure 79: Europe Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033
Figure 80: Europe Market Attractiveness Analysis , by Country
Figure 81: Europe Market Attractiveness Analysis, By Diagnosis & Treatment Type
Figure 82: Europe Market Attractiveness, By Indication
Figure 83: Europe Market Attractiveness Analysis , by Distribution Channel
Figure 84: Europe Market Attractiveness Analysis, By Service Provider
Figure 85: Germany Market Value Proportion Analysis, 2022
Figure 86: Global Vs. Germany Growth Comparison, 2022-2033
Figure 87: Germany Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 88: Germany Market Share Analysis (%), By Indication, 2022 & 2033
Figure 89: Germany Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 90: Germany Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 91: Italy Market Value Proportion Analysis, 2022
Figure 92: Global Vs. Italy Growth Comparison, 2022-2033
Figure 93: Italy Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 94: Italy Market Share Analysis (%), By Indication, 2022 & 2033
Figure 95: Italy Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 96: Italy Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 97: France Market Value Proportion Analysis, 2022
Figure 98: Global Vs. France Growth Comparison, 2022-2033
Figure 99: France Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 100: France Market Share Analysis (%), By Indication, 2022 & 2033
Figure 101: France Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 102: France Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 103: United Kingdom Market Value Proportion Analysis, 2022
Figure 104: Global Vs. United Kingdom Growth Comparison, 2022-2033
Figure 105: United Kingdom Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 106: United Kingdom Market Share Analysis (%), By Indication, 2022 & 2033
Figure 107: United Kingdom Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 108: United Kingdom Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 109: Spain Market Value Proportion Analysis, 2022
Figure 110: Global Vs. Spain Growth Comparison, 2022-2033
Figure 111: Spain Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 112: Spain Market Share Analysis (%), By Indication, 2022 & 2033
Figure 113: Spain Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 114: Spain Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 115: BENELUX Market Value Proportion Analysis, 2022
Figure 116: Global Vs. BENELUX Growth Comparison, 2022-2033
Figure 117: BENELUX Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 118: BENELUX Market Share Analysis (%), By Indication, 2022 & 2033
Figure 119: BENELUX Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 120: BENELUX Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 121: Nordic Countries Market Value Proportion Analysis, 2022
Figure 122: Global Vs. Nordic Countries Growth Comparison, 2022-2033
Figure 123: Nordic Countries Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 124: Nordic Countries Market Share Analysis (%), By Indication, 2022 & 2033
Figure 125: Nordic Countries Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 126: Nordic Countries Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 127: Russia Market Value Proportion Analysis, 2022
Figure 128: Global Vs. Russia Growth Comparison, 2022-2033
Figure 129: Russia Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 130: Russia Market Share Analysis (%), By Indication, 2022 & 2033
Figure 131: Russia Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 132: Russia Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 133: South Asia Market Value Share, By Diagnosis & Treatment Type 2023 (E)
Figure 134: South Asia Market Value Share, By Indication 2023 (E)
Figure 135: South Asia Market Value Share, by Distribution Channel 2023 (E)
Figure 136: South Asia Market Value Share, by Service Provider 2023 (E)
Figure 137: South Asia Market Value Share, by Country 2023 (E)
Figure 138: South Asia Market Size (US$ Million) Analysis, 2012 to 2022
Figure 139: South Asia Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033
Figure 140: South Asia Market Attractiveness Analysis , by Country
Figure 141: South Asia Market Attractiveness Analysis, By Diagnosis & Treatment Type
Figure 142: South Asia Market Attractiveness, By Indication
Figure 143: South Asia Market Attractiveness Analysis , by Distribution Channel
Figure 144: South Asia Market Attractiveness Analysis, By Service Provider
Figure 145: India Market Value Proportion Analysis, 2022
Figure 146: Global Vs. India Growth Comparison, 2022-2033
Figure 147: India Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 148: India Market Share Analysis (%), By Indication, 2022 & 2033
Figure 149: India Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 150: India Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 151: Thailand Market Value Proportion Analysis, 2022
Figure 152: Global Vs. Thailand Growth Comparison, 2022-2033
Figure 153: Thailand Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 154: Thailand Market Share Analysis (%), By Indication, 2022 & 2033
Figure 155: Thailand Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 156: Thailand Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 157: Indonesia Market Value Proportion Analysis, 2022
Figure 158: Global Vs. Indonesia Growth Comparison, 2022-2033
Figure 159: Indonesia Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 160: Indonesia Market Share Analysis (%), By Indication, 2022 & 2033
Figure 161: Indonesia Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 162: Indonesia Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 163: Malaysia Market Value Proportion Analysis, 2022
Figure 164: Global Vs. Malaysia Growth Comparison, 2022-2033
Figure 165: Malaysia Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 166: Malaysia Market Share Analysis (%), By Indication, 2022 & 2033
Figure 167: Malaysia Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 168: Malaysia Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 169: Philippines Market Value Proportion Analysis, 2022
Figure 170: Global Vs. Philippines Growth Comparison, 2022-2033
Figure 171: Philippines Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 172: Philippines Market Share Analysis (%), By Indication, 2022 & 2033
Figure 173: Philippines Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 174: Philippines Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 175: Vietnam Market Value Proportion Analysis, 2022
Figure 176: Global Vs. Vietnam Growth Comparison, 2022-2033
Figure 177: Vietnam Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 178: Vietnam Market Share Analysis (%), By Indication, 2022 & 2033
Figure 179: Vietnam Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 180: Vietnam Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 181: East Asia Market Value Share, By Diagnosis & Treatment Type 2023 (E)
Figure 182: East Asia Market Value Share, By Indication 2023 (E)
Figure 183: East Asia Market Value Share, by Distribution Channel 2023 (E)
Figure 184: East Asia Market Value Share, by Service Provider 2023 (E)
Figure 185: East Asia Market Value Share, by Country 2023 (E)
Figure 186: East Asia Market Size (US$ Million) Analysis, 2012 to 2022
Figure 187: East Asia Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033
Figure 188: East Asia Market Attractiveness Analysis , by Country
Figure 189: East Asia Market Attractiveness Analysis, By Diagnosis & Treatment Type
Figure 190: East Asia Market Attractiveness, By Indication
Figure 191: East Asia Market Attractiveness Analysis , by Distribution Channel
Figure 192: East Asia Market Attractiveness Analysis, By Service Provider
Figure 193: China Market Value Proportion Analysis, 2022
Figure 194: Global Vs. China Growth Comparison, 2022-2033
Figure 195: China Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 196: China Market Share Analysis (%), By Indication, 2022 & 2033
Figure 197: China Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 198: China Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 199: Japan Market Value Proportion Analysis, 2022
Figure 200: Global Vs. Japan Growth Comparison, 2022-2033
Figure 201: Japan Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 202: Japan Market Share Analysis (%), By Indication, 2022 & 2033
Figure 203: Japan Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 204: Japan Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 205: South Korea Market Value Proportion Analysis, 2022
Figure 206: Global Vs. South Korea Growth Comparison, 2022-2033
Figure 207: South Korea Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 208: South Korea Market Share Analysis (%), By Indication, 2022 & 2033
Figure 209: South Korea Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 210: South Korea Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 211: Oceania Market Value Share, By Diagnosis & Treatment Type 2023 (E)
Figure 212: Oceania Market Value Share, By Indication 2023 (E)
Figure 213: Oceania Market Value Share, by Distribution Channel 2023 (E)
Figure 214: Oceania Market Value Share, by Service Provider 2023 (E)
Figure 215: Oceania Market Value Share, by Country 2023 (E)
Figure 216: Oceania Market Size (US$ Million) Analysis, 2012 to 2022
Figure 217: Oceania Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033
Figure 218: Oceania Market Attractiveness Analysis , by Country
Figure 219: Oceania Market Attractiveness Analysis, By Diagnosis & Treatment Type
Figure 220: Oceania Market Attractiveness, By Indication
Figure 221: Oceania Market Attractiveness Analysis , by Distribution Channel
Figure 222: Oceania Market Attractiveness Analysis, By Service Provider
Figure 223: Australia Market Value Proportion Analysis, 2022
Figure 224: Global Vs. Australia Growth Comparison, 2022-2033
Figure 225: Australia Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 226: Australia Market Share Analysis (%), By Indication, 2022 & 2033
Figure 227: Australia Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 228: Australia Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 229: New Zealand Market Value Proportion Analysis, 2022
Figure 230: Global Vs. New Zealand Growth Comparison, 2022-2033
Figure 231: New Zealand Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 232: New Zealand Market Share Analysis (%), By Indication, 2022 & 2033
Figure 233: New Zealand Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 234: New Zealand Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 235: Middle East & Africa Market Value Share, By Diagnosis & Treatment Type 2023 (E)
Figure 236: Middle East & Africa Market Value Share, By Indication 2023 (E)
Figure 237: Middle East & Africa Market Value Share, by Distribution Channel 2023 (E)
Figure 238: Middle East & Africa Market Value Share, by Service Provider 2023 (E)
Figure 239: Middle East & Africa Market Value Share, by Country 2023 (E)
Figure 240: Middle East & Africa Market Size (US$ Million) Analysis, 2012 to 2022
Figure 241: Middle East & Africa Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2023 to 2033
Figure 242: Middle East & Africa Market Attractiveness Analysis, by Country
Figure 243: Middle East & Africa Market Attractiveness Analysis, By Diagnosis & Treatment Type
Figure 244: Middle East & Africa Market Attractiveness, By Indication
Figure 245: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel
Figure 246: Middle East & Africa Market Attractiveness Analysis, By Service Provider
Figure 247: GCC Countries Market Value Proportion Analysis, 2022
Figure 248: Global Vs. GCC Countries Growth Comparison, 2022-2033
Figure 249: GCC Countries Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 250: GCC Countries Market Share Analysis (%), By Indication, 2022 & 2033
Figure 251: GCC Countries Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 252: GCC Countries Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 253: Türkiye Market Value Proportion Analysis, 2022
Figure 254: Global Vs. Türkiye Growth Comparison, 2022-2033
Figure 255: Türkiye Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 256: Türkiye Market Share Analysis (%), By Indication, 2022 & 2033
Figure 257: Türkiye Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 258: Türkiye Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 259: South Africa Market Value Proportion Analysis, 2022
Figure 260: Global Vs. South Africa Growth Comparison, 2022-2033
Figure 261: South Africa Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 262: South Africa Market Share Analysis (%), By Indication, 2022 & 2033
Figure 263: South Africa Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 264: South Africa Market Share Analysis (%), By Service Providers, 2022 & 2033
Figure 265: North Africa Market Value Proportion Analysis, 2022
Figure 266: Global Vs. North Africa Growth Comparison, 2022-2033
Figure 267: North Africa Market Share Analysis (%), By Diagnosis & Treatment Type, 2022 & 2033
Figure 268: North Africa Market Share Analysis (%), By Indication, 2022 & 2033
Figure 269: North Africa Market Share Analysis (%), By Distribution Channel, 2022 & 2033
Figure 270: North Africa Market Share Analysis (%), By Service Providers, 2022 & 2033
The global market is valued around USD 12.2 Billion in 2022.
The global market estimates for 2023 is around USD 13.1 Billion.
The global market is set to reach USD 28.4 Billion by the end of 2033, with sales revenue expected to be 8.1% CAGR through 2033.
North America dominated the global market in 2022 with the USA being the leading contributor in the North American region.
Rising demand for improved brain and mental fitness and improving healthcare infrastructure to offer lucrative growth opportunities for the market players to grow.
Cerebral palsy segment dominated the global market in 2022 with 14.4% revenue share and is expected to lead in 2023 as well.
The USA, India, China, Germany and United Kingdom are the top countries that are driving the demand for the spasticity treatment globally.
From 2012 to 2022, the market for spasticity treatment expanded at the rate of 5.4%.
Allergan plc. (AbbVie), F. Hoffmann-La Roche Ltd, Pfizer Inc., Medtronic Plc, GlaxoSmithKline plc, are few key players within the global market.
China is projected to grow with CAGR of 7.7% over the forecast duration.
Explore Similar Insights
Spasticity Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
